PL2066677T3 - Pirydooksazepiny jako modulatory receptora progesteronowego - Google Patents

Pirydooksazepiny jako modulatory receptora progesteronowego

Info

Publication number: PL2066677T3
Authority: PL; Poland
Prior art keywords: pyridooxazepine; receptor modulators; progesteron receptor; progesteron; modulators
Prior art date: 2006-09-27

Application number

PL07820620T

Other languages

English (en)

Inventor

Johannes Bernardus Maria Rewinkel

Brigitte Johanna Bernita Folmer

Maria Lourdes Ollero-Ollero

Hemen Ibrahim

Original Assignee

N V Organon

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-09-27

Filing date

2007-09-26

Publication date

2011-02-28

2007-09-26 Application filed by N V Organon filed Critical N V Organon

2011-02-28 Publication of PL2066677T3 publication Critical patent/PL2066677T3/pl

Links

102000003998 progesterone receptors Human genes 0.000 title 1
108090000468 progesterone receptors Proteins 0.000 title 1
PPEUWCVFFQXSKB-UHFFFAOYSA-N pyrido[2,3-f]oxazepine Chemical compound O1N=CC=CC2=NC=CC=C12 PPEUWCVFFQXSKB-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Reproductive Health (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Vascular Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PL07820620T 2006-09-27 2007-09-26 Pirydooksazepiny jako modulatory receptora progesteronowego PL2066677T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP06121372		2006-09-27
EP07820620A EP2066677B1 (en)	2006-09-27	2007-09-26	Pyridooxazepine progesteron receptor modulators
PCT/EP2007/060225 WO2008037746A1 (en)	2006-09-27	2007-09-26	Pyridooxazepine progesteron receptor modulators

Publications (1)

Publication Number	Publication Date
PL2066677T3 true PL2066677T3 (pl)	2011-02-28

Family

ID=37813577

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL07820620T PL2066677T3 (pl)	2006-09-27	2007-09-26	Pirydooksazepiny jako modulatory receptora progesteronowego

Country Status (27)

Country	Link
EP (1)	EP2066677B1 (pl)
JP (1)	JP2010504943A (pl)
KR (1)	KR20090064454A (pl)
CN (1)	CN101522689B (pl)
AR (1)	AR063018A1 (pl)
AT (1)	ATE478078T1 (pl)
AU (1)	AU2007302007B2 (pl)
BR (1)	BRPI0716830A2 (pl)
CA (1)	CA2664120A1 (pl)
CL (1)	CL2007002788A1 (pl)
CO (1)	CO6160325A2 (pl)
CY (1)	CY1110846T1 (pl)
DE (1)	DE602007008589D1 (pl)
DK (1)	DK2066677T3 (pl)
ES (1)	ES2349325T3 (pl)
HR (1)	HRP20100526T1 (pl)
IL (1)	IL197365A0 (pl)
MX (1)	MX2009002804A (pl)
NO (1)	NO20091016L (pl)
NZ (1)	NZ575276A (pl)
PE (1)	PE20071451A1 (pl)
PL (1)	PL2066677T3 (pl)
PT (1)	PT2066677E (pl)
RU (1)	RU2009115643A (pl)
SI (1)	SI2066677T1 (pl)
TW (1)	TW200820975A (pl)
WO (1)	WO2008037746A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI297685B (en)	2002-04-04	2008-06-11	Organon Nv	Non-steroidal progesterone receptor modulators
CN101200429B (zh) *	2006-12-13	2012-08-22	上海睿智化学研究有限公司	2-硝基-4,5-二卤代苯酚类和2-氨基-4,5-二卤代苯酚类及其盐及其合成方法
US8063037B2 (en)	2007-05-07	2011-11-22	N. V. Organon	Progesterone receptor modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002020526A2 (en) *	2000-09-07	2002-03-14	Bayer Pharmaceuticals Corporation	Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
TWI297685B (en) *	2002-04-04	2008-06-11	Organon Nv	Non-steroidal progesterone receptor modulators

2007
- 2007-09-26 HR HR20100526T patent/HRP20100526T1/hr unknown
- 2007-09-26 CA CA002664120A patent/CA2664120A1/en not_active Abandoned
- 2007-09-26 JP JP2009529699A patent/JP2010504943A/ja not_active Ceased
- 2007-09-26 CN CN2007800361667A patent/CN101522689B/zh not_active Expired - Fee Related
- 2007-09-26 DE DE602007008589T patent/DE602007008589D1/de active Active
- 2007-09-26 RU RU2009115643/04A patent/RU2009115643A/ru not_active Application Discontinuation
- 2007-09-26 EP EP07820620A patent/EP2066677B1/en active Active
- 2007-09-26 BR BRPI0716830-6A patent/BRPI0716830A2/pt not_active IP Right Cessation
- 2007-09-26 DK DK07820620.8T patent/DK2066677T3/da active
- 2007-09-26 AT AT07820620T patent/ATE478078T1/de active
- 2007-09-26 AU AU2007302007A patent/AU2007302007B2/en not_active Ceased
- 2007-09-26 TW TW096135743A patent/TW200820975A/zh unknown
- 2007-09-26 MX MX2009002804A patent/MX2009002804A/es not_active Application Discontinuation
- 2007-09-26 PT PT07820620T patent/PT2066677E/pt unknown
- 2007-09-26 PL PL07820620T patent/PL2066677T3/pl unknown
- 2007-09-26 WO PCT/EP2007/060225 patent/WO2008037746A1/en not_active Ceased
- 2007-09-26 KR KR1020097007645A patent/KR20090064454A/ko not_active Withdrawn
- 2007-09-26 ES ES07820620T patent/ES2349325T3/es active Active
- 2007-09-26 NZ NZ575276A patent/NZ575276A/en unknown
- 2007-09-26 SI SI200730404T patent/SI2066677T1/sl unknown
- 2007-09-27 CL CL200702788A patent/CL2007002788A1/es unknown
- 2007-09-27 PE PE2007001315A patent/PE20071451A1/es not_active Application Discontinuation
- 2007-09-27 AR ARP070104267A patent/AR063018A1/es not_active Application Discontinuation
2009
- 2009-03-03 IL IL197365A patent/IL197365A0/en unknown
- 2009-03-06 NO NO20091016A patent/NO20091016L/no not_active Application Discontinuation
- 2009-03-27 CO CO09031994A patent/CO6160325A2/es unknown
2010
- 2010-10-21 CY CY20101100942T patent/CY1110846T1/el unknown

Also Published As

Publication number	Publication date
ES2349325T3 (es)	2010-12-30
HK1126767A1 (en)	2009-09-11
MX2009002804A (es)	2009-03-31
IL197365A0 (en)	2009-12-24
CY1110846T1 (el)	2015-06-10
PT2066677E (pt)	2010-11-10
BRPI0716830A2 (pt)	2013-11-05
HRP20100526T1 (hr)	2010-11-30
NZ575276A (en)	2011-07-29
CN101522689A (zh)	2009-09-02
SI2066677T1 (sl)	2010-12-31
EP2066677A1 (en)	2009-06-10
DK2066677T3 (da)	2010-11-08
RU2009115643A (ru)	2010-11-10
CA2664120A1 (en)	2008-04-03
CN101522689B (zh)	2012-01-11
AU2007302007B2 (en)	2012-02-02
PE20071451A1 (es)	2008-10-30
AR063018A1 (es)	2008-12-23
JP2010504943A (ja)	2010-02-18
WO2008037746A1 (en)	2008-04-03
DE602007008589D1 (de)	2010-09-30
KR20090064454A (ko)	2009-06-18
ATE478078T1 (de)	2010-09-15
CL2007002788A1 (es)	2008-04-18
TW200820975A (en)	2008-05-16
CO6160325A2 (es)	2010-05-20
NO20091016L (no)	2009-03-30
AU2007302007A1 (en)	2008-04-03
EP2066677B1 (en)	2010-08-18

Publication	Publication Date	Title
EP2179061A4 (en)	2010-09-08	GREAT LIKE RECEPTOR MODULATORS
ZA200807551B (en)	2009-06-24	Selective androgen receptor modulators
EP2100186A4 (en)	2010-12-01	ELECTROCHROMIC DEVICE
IL198990A0 (en)	2010-02-17	Cb1 receptor modulators
GB0701992D0 (en)	2007-03-14	Grehlin Receptor Modulators
IL191766A0 (en)	2008-12-29	Gaba-b receptor modulators
IL195997A0 (en)	2009-09-01	Catecholamine receptor modulation
IL204786A0 (en)	2010-11-30	Benzyl - cycloalkyl sphingosing 1 - phosphate receptor modulators
ZA201004828B (en)	2011-03-30	Cannabinoid receptor modulators
ZA201002268B (en)	2011-10-26	Benzothiazoles as ghrelin receptor modulators
GB0618026D0 (en)	2006-10-25	Tiling system
ZA200809329B (en)	2010-01-27	Applicator device
GB0613057D0 (en)	2006-08-09	Applicator unit
IL197365A0 (en)	2009-12-24	Pyridooxazepine progesteron receptor modulators
GB0705829D0 (en)	2007-05-02	Waste receptor
ZA200806237B (en)	2009-05-27	Cannibinoid receptor modulators
GB0622569D0 (en)	2006-12-20	Cannabinoid receptor modulators
GB0625168D0 (en)	2007-01-24	Fixing device
ZA200907546B (en)	2010-07-28	New progesterone receptor modulators
ZA200904663B (en)	2010-05-26	CB1 receptor modulators
GB2440335B (en)	2008-10-15	Fixing Apparatus
HK1122811A (en)	2009-05-29	Cannibinoid receptor modulators
GB0623399D0 (en)	2007-01-03	Receptor
GB0604684D0 (en)	2006-04-19	Receptor
GB0608516D0 (en)	2006-06-07	Receptor